ClinicalTrials.Veeva

Menu

Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

Allergan logo

Allergan

Status and phase

Completed
Phase 3

Conditions

Dry Eye Syndromes

Treatments

Drug: Carboxymethylcellulose Based Eye Drop Formulation B
Drug: Carboxymethylcellulose Based Lubricant Eye Drops
Drug: Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops
Drug: Carboxymethylcellulose Based Eye Drop Formulation A

Study type

Interventional

Funder types

Industry

Identifiers

NCT01459588
10146X-001

Details and patient eligibility

About

This study will evaluate the safety, efficacy, and acceptability of an eye drop formulation in subjects with dry eye disease.

Enrollment

315 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Dry eyes
  • Current use of eye drops for dry eye at least twice daily, on average for at least 3 months

Exclusion criteria

  • Cataract, laser-assisted in situ keratomileusis (LASIK), or photorefractive keratectomy (PRK) surgery in the last 12 months
  • Need to wear contact lenses during the study, or has worn contact lenses in the last 6 months
  • Active ocular allergy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

315 participants in 4 patient groups

Carboxymethylcellulose Based Eye Drop Formulation A
Experimental group
Description:
Carboxymethylcellulose Based Eye Drop Formulation A (Refresh Optive® Advanced Sensitive Eye Drops) 1-2 drops in each eye as needed, at least 2 times daily for 30 days.
Treatment:
Drug: Carboxymethylcellulose Based Eye Drop Formulation A
Carboxymethylcellulose Based Eye Drop Formulation B
Experimental group
Description:
Carboxymethylcellulose Based Eye Drop Formulation B (Refresh Optive® Advanced Eye Drops) 1-2 drops in each eye as needed at least 2 times daily for 30 days.
Treatment:
Drug: Carboxymethylcellulose Based Eye Drop Formulation B
Carboxymethylcellulose Preservative-Free Lubricant Eye Drops
Active Comparator group
Description:
Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops (Optive® Sensitive Preservative-Free Lubricant Eye Drops) 1-2 drops in each eye as needed at least 2 times daily for 30 days.
Treatment:
Drug: Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops
Carboxymethylcellulose Based Lubricant Eye Drops
Active Comparator group
Description:
Carboxymethylcellulose Based Lubricant Eye Drops (Optive® Lubricant Eye Drops) 1-2 drops in each eye as needed, at least 2 times daily for 30 days.
Treatment:
Drug: Carboxymethylcellulose Based Lubricant Eye Drops

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems